Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens

Claudia Marchetti; Filippo Bellati; Angela Musella; Chiara Napoletano; Giorgia Perniola; Violante Di Donato; Sandro Pignata; Marianna Nuti; Pierluigi Benedetti Panici

doi:10.1007/s10147-011-0300-9

Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens

Claudia Marchetti, Filippo Bellati, Angela Musella, Chiara Napoletano, Giorgia Perniola, Violante Di Donato, Sandro Pignata, Marianna Nuti, Pierluigi Benedetti Panici

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

We present two cases of advanced ovarian cancer treated with neoadjuvant chemotherapy with standard tri-weekly carboplatin and paclitaxel. Therapy was converted to weekly regimens because of disease progression, resulting in disease response. Weekly regimens could overcome drug resistance and this strategy should be attempted before abandoning first-line chemotherapy in favor of palliation. © Japan Society of Clinical Oncology 2012.

Lingua originale	English
pagine (da-a)	385-389
Numero di pagine	5
Rivista	International Journal of Clinical Oncology
Volume	17
DOI	https://doi.org/10.1007/s10147-011-0300-9
Stato di pubblicazione	Pubblicato - 2012

Keywords

Carboplatin
Ovarian cancer
Weekly paclitaxel

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1007/s10147-011-0300-9

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Marchetti, C., Bellati, F., Musella, A., Napoletano, C., Perniola, G., Di Donato, V., Pignata, S., Nuti, M., & Panici, P. B. (2012). Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens. International Journal of Clinical Oncology, 17, 385-389. https://doi.org/10.1007/s10147-011-0300-9

@article{60ee4a63a80940a79e818563fd64aad4,

title = "Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens",

abstract = "We present two cases of advanced ovarian cancer treated with neoadjuvant chemotherapy with standard tri-weekly carboplatin and paclitaxel. Therapy was converted to weekly regimens because of disease progression, resulting in disease response. Weekly regimens could overcome drug resistance and this strategy should be attempted before abandoning first-line chemotherapy in favor of palliation. {\textcopyright} Japan Society of Clinical Oncology 2012.",

keywords = "Carboplatin, Ovarian cancer, Weekly paclitaxel, Carboplatin, Ovarian cancer, Weekly paclitaxel",

author = "Claudia Marchetti and Filippo Bellati and Angela Musella and Chiara Napoletano and Giorgia Perniola and {Di Donato}, Violante and Sandro Pignata and Marianna Nuti and Panici, {Pierluigi Benedetti}",

year = "2012",

doi = "10.1007/s10147-011-0300-9",

language = "English",

volume = "17",

pages = "385--389",

journal = "International Journal of Clinical Oncology",

issn = "1341-9625",

publisher = "Springer Japan",

}

Marchetti, C, Bellati, F, Musella, A, Napoletano, C, Perniola, G, Di Donato, V, Pignata, S, Nuti, M & Panici, PB 2012, 'Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens', International Journal of Clinical Oncology, vol. 17, pagg. 385-389. https://doi.org/10.1007/s10147-011-0300-9

Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens. / Marchetti, Claudia; Bellati, Filippo; Musella, Angela et al.
In: International Journal of Clinical Oncology, Vol. 17, 2012, pag. 385-389.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens

AU - Marchetti, Claudia

AU - Bellati, Filippo

AU - Musella, Angela

AU - Napoletano, Chiara

AU - Perniola, Giorgia

AU - Di Donato, Violante

AU - Pignata, Sandro

AU - Nuti, Marianna

AU - Panici, Pierluigi Benedetti

PY - 2012

Y1 - 2012

N2 - We present two cases of advanced ovarian cancer treated with neoadjuvant chemotherapy with standard tri-weekly carboplatin and paclitaxel. Therapy was converted to weekly regimens because of disease progression, resulting in disease response. Weekly regimens could overcome drug resistance and this strategy should be attempted before abandoning first-line chemotherapy in favor of palliation. © Japan Society of Clinical Oncology 2012.

AB - We present two cases of advanced ovarian cancer treated with neoadjuvant chemotherapy with standard tri-weekly carboplatin and paclitaxel. Therapy was converted to weekly regimens because of disease progression, resulting in disease response. Weekly regimens could overcome drug resistance and this strategy should be attempted before abandoning first-line chemotherapy in favor of palliation. © Japan Society of Clinical Oncology 2012.

KW - Carboplatin

KW - Ovarian cancer

KW - Weekly paclitaxel

KW - Carboplatin

KW - Ovarian cancer

KW - Weekly paclitaxel

UR - http://hdl.handle.net/10807/203924

U2 - 10.1007/s10147-011-0300-9

DO - 10.1007/s10147-011-0300-9

M3 - Article

SN - 1341-9625

VL - 17

SP - 385

EP - 389

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

ER -

Thinking twice before abandoning first-line chemotherapy in ovarian cancer: Report of two cases and literature review. Passing from tri-weekly to weekly regimens

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo